Abacavir
Ziagen (abacavir) is a small molecule pharmaceutical. Abacavir was first approved as Ziagen on 1998-12-17. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections. The pharmaceutical is active against Gag-Pol and Gag-Pol polyprotein.
| Trade Name | Ziagen |
|---|---|
| Common Name | Abacavir |
| Indication | acquired immunodeficiency syndrome, hiv infections |
| Drug Class | Antivirals: carbocyclic nucleosides |
